Established Products Business Unit
In this section you will find information and resources for journalists who are writing about Pfizer's Established Products Business Unit, including press releases, a fact sheet, and background information about some of the business unit's key leaders.
- October 1, 2009 — Pfizer Expands Established Products Portfolio with the Launch of their Off-Patent Sterile Injectables Business
- May 20, 2009 — Pfizer Expands Its Generics Portfolio through Innovative Licensing Deals, Increasing Access to Medicines for Billions Worldwide
- Established Products Leadership Team Bios
- Established Products Fact Sheet
Stock Quote Disclaimer
20 minute delayed data provided by Comstock. Charts are provided by BigCharts and MarketWatch, Inc. Pfizer makes no claims concerning the accuracy of the information provided on these pages, and will not be held liable for any use of this information. Note: Historical and current stock price performance data is not necessarily indicative of future performance.
Stock Symbol: PFE Stock Exchange: NYSE
Stock Quote at: Nov 20 2009 4:00PM
| Last 18.36 | Change 0.25 |
| %Change | 1.38 | Vol. | 60,966,550 |
| Day High | 18.48 | 52 Wk. High | 18.48 |
| Day Low | 18.12 | 52 Wk. Low | 11.62 |
| Open | 18.15 | Mkt. Cap(Bil) | 148.16 |
| Prev. Close | 18.11 |
Pfizer Annual Review:
Doing Things Differently
We are becoming the Pfizer we are meant to be — one that can offer healthy solutions at every stage of life.
- Contact Us
- Investors
- Sitemap
- Careers
- Business to Business
- Terms of Use
- Global Network
- Privacy Policy
Copyright © 2002–2009 Pfizer Inc. All rights reserved. This information is intended only for residents of the United States. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries. Pfizer Inc is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
